Spoiler alert! We're talking aboutthe biggest reveals in "Backrooms" (in theaters now) and the movie's ending, so turn away if you haven't seen it yet. The world of "Backrooms" isn't done expanding.
The Backrooms movie will be released in theaters on May 29. Liminal spaces – dreamy and nostalgic locales defined by their specific use as a transient space that you don’t spend much time in but ...
Be careful what you wish for. This idea, often explored in fiction, lies at the center of “Obsession,” Focus Features‘ new horror film from writer/director/editor Curry Barker. The movie follows Bear ...
The Vampire Crawlers: The Turbo Wildcard from Vampire Survivors' combo system is the most powerful feature in the game, yet it's easily overlooked. If you play your cards in a certain order, you will ...
‘Lee Cronin’s The Mummy’ reimagines the classic horror icon as a demonic entity contained by the body it possesses—here’s the twist ending, explained. This voice experience is generated by AI. Learn ...
A pair of rivals developing drugs for common retinal diseases are not seeing eye to eye. EyePoint on Friday filed a lawsuit in Massachusetts Superior Court accusing Ocular Therapeutix of engaging in a ...
March 20 (Reuters) - EyePoint (EYPT.O), opens new tab filed a lawsuit on Friday accusing rival Ocular Therapeutix (OCUL.O), opens new tab of spreading false or misleading information about EyePoint ...
It is a hot afternoon in a rural district in Malawi. People gather around a tent set up at the Local Trading Center, eager to witness a community outreach program that aims to combat rising violence ...
The UN independent expert on the enjoyment of human rights by persons with albinism called on member states Monday to take further steps to promote employment rights for persons with albinism through ...
At least 30 blue whales have been spotted in the waters of Loreto Bay National Park this season Michael Nied has been a digital news editor with PEOPLE since 2025. He has previously been published by ...
An Ocular Therapeutix drug developed for the wet form of age-related macular degeneration was better at helping patients maintain vision compared to a blockbuster Regeneron Pharmaceuticals drug that ...